Role of IL28B genotype in older hepatitis C virus-infected patients

Table 3 Severe adverse events in hepatitis C patients aged ≥ 65 years and treated with standard of care n (%)

Severe adverse events	No. of patient
	discontinuities
Occurrence of malignancies (Hepatocellular carcinoma)	5 (13.5)
Severe fatigue	5 (13.5)
Severe pulmonary symptoms (bloody phlegm, cough, or interstitial pneumonitis)	5 (13.5)
Severe anemia	5 (13.5)
Psychiatric disorders	3 (8.1)
Severe skin lesion	3 (8.1)
Neurological disorders	3 (8.1)
Severe thrombocytopenia or neutropenia	3 (8.1)
Severe denutrition	2 (5.4)
Upper gastrointestinal bleeding	1 (2.7)
Severe infection (tuberculosis)	1 (2.7)
Unknown	1 (2.7)